Thermal Cyclers Market Report 2026

The thermal cyclers market size has grown strongly in recent years. It will grow from $1.29 billion in 2025 to $1.4 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to growth in molecular diagnostics, expansion of genomics research, rise in infectious disease testing, increase in forensic analysis, growth in academic research labs.

The thermal cyclers market size is expected to see strong growth in the next few years. It will grow to $1.98 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to expansion of point of care testing, growth in precision medicine, rising demand for rapid diagnostics, increase in biotech research funding, wider adoption of digital PCR. Major trends in the forecast period include high throughput pcr cycler systems, portable field deployable cyclers, AI assisted temperature optimization, cloud connected pcr platforms, rapid cycling thermal blocks.

The growing adoption of advanced genetic testing technologies is anticipated to drive the expansion of the thermal cyclers market in the coming years. Molecular diagnostics encompasses advanced laboratory methods used to detect and analyze genetic material (DNA and RNA) for the identification of diseases, infections, and genetic disorders with high precision. The growth in molecular diagnostics is fueled by the rising demand for early and accurate disease detection, which is promoting the use of advanced genetic testing techniques to achieve faster and more dependable clinical outcomes. Thermal cyclers facilitate molecular diagnostics by enabling precise DNA amplification via controlled temperature cycles, ensuring accurate, rapid, and reliable molecular analysis. For example, in May 2025, according to Ellume, an Australia-based developer of rapid digital diagnostic tests, over 96,215 molecular diagnostic tests were performed per week in the US in 2023, demonstrating widespread clinical use and the sustained importance of molecular diagnostics in disease monitoring and clinical decision-making. Therefore, the growing adoption of advanced genetic testing technologies is fueling the expansion of the thermal cyclers market.

Leading companies operating in the thermal cyclers market are focusing on advanced innovations such as deep-well thermal cyclers to gain a competitive edge in the market. Deep-well thermal cyclers are specialized laboratory instruments used to perform temperature-controlled reactions, such as PCR, on samples contained in deep-well plates, which hold larger volumes than standard PCR tubes or plates. For example, in March 2025, Bio-Rad Laboratories, a US-based research company, launched the PTC Tempo 384 Thermal Cycler, the latest model in its PTC Tempo series. This advanced instrument is specifically designed for high-throughput PCR applications in basic research, translational studies, process development, and quality control. The PTC Tempo 384 features a 384-well reaction module equipped with a motorized lid, allowing for seamless automation and integration with robotics. It delivers superior thermal uniformity (±0.3°C at 95°C), dynamic ramp rates of up to 5°C per second, and multizone gradient programming, making it more efficient than other models, such as the dual-block PTC Tempo 48/48, for demanding, scalable workflows. Built on the trusted C1000 Touch platform, the PTC Tempo 384 comes with an updated intuitive user interface, flexible connectivity options including BR.io cloud monitoring, and the recent software update v3.0.0.8 that enhances API support. This makes the PTC Tempo 384 an excellent choice for academic, commercial, and biopharma laboratories, offering unmatched reproducibility and usability.

In February 2025, Bio‑Rad Laboratories, a US-based company that manufactures life science and clinical diagnostic products, acquired Stilla Technologies for an undisclosed amount. Through this acquisition, Bio‑Rad Laboratories seeks to expand its digital PCR portfolio and accelerate the advancement of next-generation digital PCR solutions, offering higher automation, increased throughput, and a comprehensive range of applications in genomics research, clinical diagnostics, and applied life sciences. Stilla Technologies is a France-based company specializing in next-generation digital PCR instruments, assays, and thermal cyclers for genomics, clinical diagnostics, and molecular research applications.

Major companies operating in the thermal cyclers market are Roche Diagnostics, Thermo Fisher Scientific Inc., Agilent Technologies, Bio-Rad Laboratories, QIAGEN, Eppendorf, Cepheid, Bio-Techne, Hamilton Company, Heal Force Bio-Meditech, Takara Bio, Hangzhou Bioer Technology, Analytik Jena, Esco Lifesciences, ELITechGroup, Benchmark Scientific, Cole-Parmer Instrument Company, Biomeme, GNA Biosolutions, Cleaver Scientific, Starlab International, and Scilogex.

Tariffs are impacting the thermal cyclers market by increasing the cost of imported precision sensors, control electronics, and laboratory instrument components. Higher duties are raising prices for standard PCR, qPCR, and digital PCR systems. Research and diagnostic laboratory segments that rely on imported instruments are facing higher capital costs. Regions dependent on cross border lab equipment trade are seeing procurement delays and budget pressure. Suppliers are expanding regional manufacturing and local assembly operations. Tariffs are also encouraging domestic production of laboratory instruments. This supports regional lab equipment ecosystems and improves supply stability.

The thermal cyclers market research report is one of a series of new reports that provides thermal cyclers market statistics, including thermal cyclers industry global market size, regional shares, competitors with a thermal cyclers market share, detailed thermal cyclers market segments, market trends and opportunities, and any further data you may need to thrive in the thermal cyclers industry. This thermal cyclers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Thermal cyclers are laboratory devices engineered to precisely control repeated temperature changes required for automated heating and cooling of biological samples. These instruments feature programmable temperature settings, rapid thermal transitions, and uniform heat distribution across samples to ensure consistent results. They are essential for accurate molecular and biochemical processes in research, diagnostics, and clinical laboratory environments.

The primary product types of thermal cyclers include standard polymerase chain reaction (PCR) thermal cyclers, real-time PCR (qPCR) systems, digital PCR (dPCR) systems, high-throughput thermal cyclers, and portable or compact thermal cyclers. Standard PCR thermal cyclers refer to instruments that amplify DNA sequences through repeated heating and cooling cycles using the polymerase chain reaction process. These systems employ technologies such as gradient PCR, touchdown PCR, fast PCR, reverse transcription PCR (RT-PCR), and other related technologies. They are applied across clinical diagnostics, research and academic use, forensic applications, agricultural biotechnology, and environmental testing. They are distributed via direct sales, distributors or resellers, and online sales, and are utilized by end users including hospitals and diagnostic centers, academic and research institutions, biotechnology and pharmaceutical companies, forensic laboratories, and contract research organizations (CROs).

The thermal cyclers market consists of sales of thermal cycling chambers, environmental test systems, and temperature control and monitoring equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.